Clinical Trial Update: Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of vilazodone in patients with Major depressive disorder, including exploration of genetic markers associated with response;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

Sponsor: Pharmacology Research Institute | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED